| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Dysuria | FAERS: 4 | US FAERS | |
| 2 | Blood urine present | FAERS: 3 | US FAERS | |
| 3 | Urinary tract infection | FAERS: 3 | US FAERS | |
| 4 | Extravasation | FAERS: 2 | US FAERS | |
| 5 | Hypotension | FAERS: 2 | US FAERS | |
| 6 | Nausea | FAERS: 2 | US FAERS | |
| 7 | Pharmaceutical product complaint | FAERS: 2 | US FAERS | |
| 8 | Throat irritation | FAERS: 2 | US FAERS | |
| 9 | Thrombosis | FAERS: 2 | US FAERS | |
| 10 | Urinary Incontinence | FAERS: 2 | US FAERS | |
| 11 | Vomiting | FAERS: 2 | US FAERS | |
| 12 | Accidental overdose | FAERS: 1 | US FAERS | |
| 13 | Bronchospasm | FAERS: 1 | US FAERS | |
| 14 | Dizziness | FAERS: 1 | US FAERS | |
| 15 | Drug ineffective for unapproved indication | FAERS: 1 | US FAERS | |
| 16 | Extremity necrosis | FAERS: 1 | US FAERS | |
| 17 | Flushing | FAERS: 1 | US FAERS | |
| 18 | Headache | FAERS: 1 | US FAERS | |
| 19 | Hypersensitivity | FAERS: 1 | US FAERS | |
| 20 | Infusion site reaction | FAERS: 1 | US FAERS | |
| 21 | No adverse reaction | FAERS: 1 | US FAERS | |
| 22 | Palpitations | FAERS: 1 | US FAERS | |
| 23 | Presyncope | FAERS: 1 | US FAERS | |
| 24 | Product use in unapproved indication | FAERS: 1 | US FAERS | |
| 25 | Tinnitus | FAERS: 1 | US FAERS | |
| 26 | Unevaluable event | FAERS: 1 | US FAERS | |
| 27 | Urticaria | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.